(Q34168868)

31 July 2017

title

Ligand-directed targeting of genes to the site of disease (English)

1 reference

31 July 2017

Thomas J Wickham

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

31 July 2017

1 reference

31 July 2017

volume

9

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

135-139

1 reference

A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Adenovirus binding to the coxsackievirus and adenovirus receptor or integrins is not required to elicit brain inflammation but is necessary to transduce specific neural cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Development of novel cell surface CD34-targeted recombinant adenoassociated virus vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Targeted gene delivery by tropism-modified adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Tumor regression by targeted gene delivery to the neovasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Retroviral vectors displaying functional antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Tissue-specific targeting of retroviral vectors through ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Masking of retroviral envelope functions by oligomerizing polypeptide adaptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Lesion-targeted injectable vectors for vascular restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Systemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

"Stealth" adenoviruses blunt cell-mediated and humoral immune responses against the virus and allow for significant gene expression upon readministration in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Dressing up adenoviruses to modify their tropism.. Interview by Florence Paillard

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Targeting tumors with non-viral gene delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Design and gene delivery activity of modified polyethylenimines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Pulmonary collectins and innate host defense of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Collectins and viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Antiviral activity of bovine collectins against rotaviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Genes expressed in human tumor endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Phage display of adenovirus type 5 fiber knob as a tool for specific ligand selection and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

In vivo selection of protease cleavage sites from retrovirus display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

A gene delivery system activatable by disease-associated matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

inferred from DOI database lookup

7 January 2021

based on heuristic

Retroviral retargeting by envelopes expressing an N-terminal binding domain.

1 reference

https://api.crossref.org/works/10.1038%2FNM0103-135

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM0103-135

1 reference

Dimensions Publication ID

31 July 2017

1008155992

0 references

1 reference